Maxwell Van Tassell

FDA investigator · also recorded as Ee Maxwell Van Tassell

Appears on 4 documents from 2017 to 2019, mostly at sites in Japan. Most often cites written procedures; deviations (21 CFR 211.100).

4
Documents on file
3.8
Observations per 483
2017
First seen
2019
Most recent

What they cite most

From 15 observations

Activity by year

2017: 1, 2019: 3

Where

Japan 2 · Massachusetts 1 · Puerto Rico 1

Is Maxwell Van Tassell coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Astellas Pharma Inc.Oct 7, 2019 · Toyama, Japan
483 Amgen Manufacturing Limited LLCMay 8, 2019 · Juncos, Puerto Rico
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJan 18, 2019 · Andover, Massachusetts
483 Chugai Pharma Manufacturing Co., LtdSep 27, 2017 · TKY, Japan

About this profile

What does Maxwell Van Tassell inspect?

Maxwell Van Tassell appears on 4 documents on file covering 4 sites, mostly in Japan.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.67 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Maxwell Van Tassell is dated Oct 7, 2019.